Hillhouse Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Hillhouse Investment Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-858,340	Closed	-$56M	–	48
2018 Q3	$56M	Hold	858,340	–	–	1.5%	12
2018 Q2	$42.6M	Buy	858,340 +100,000	+13%	+$4.84M	0.73%	25
2018 Q1	$37M	Buy	758,340 +289,340	+62%	+$15M	0.65%	24
2017 Q4	$19.7M	Buy	469,000 +276,787	+144%	+$10.7M	0.34%	26
2017 Q3	$8.24M	Buy	+192,213	New	+$6.13M	0.14%	40

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Hillhouse Investment Management's MYOK Position: Q4 2018 in Review

Hillhouse Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2018, closing a stake of 858,340 shares — an estimated $56M sold.

Hillhouse Investment Management first reported a position in MYOK in Q3 2017 and held it in 5 quarters. The position peaked at $56M in Q3 2018. 145 funds tracked by Wall St. Rank hold MYOK as of Q4 2018.

Hillhouse Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Hillhouse Investment Management sold 858,340 MyoKardia, Inc. Common Stock shares in Q4 2018, an estimated $56M.
Hillhouse Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 5 quarters.
Hillhouse Investment Management's MyoKardia, Inc. Common Stock position peaked at $56M in Q3 2018.
145 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2018.

Based on Hillhouse Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.